Pfizer Inc. (NYSE: PFE) will showcase data across its portfolio of potential breakthrough cancer medicines at the 2025 American Society of Clinical ...

Pfizer (PFE) will showcase data across its portfolio of potential breakthrough cancer medicines at the 2025 American ...

Pfizer Inc. (NYSE: PFE) will showcase data across its portfolio of potential breakthrough cancer medicines at the 2025 ...

Pfizer PFE will report its first-quarter earnings on April 29, before market open. The Zacks Consensus Estimate for sales and ...

Pfizer Inc.'s stock is trading at $22 with an 8% dividend yield, driven by market fears over losing vaccine revenues. Read ...

Pfizer Inc. (NYSE:PFE ... is leading in the US with the potential to reach 3x more patients. Braftovi/Mektovi have also experienced a 27% global sales increase year-over-year, which is supported ...

Pfizer’s PFE stock hit a new 52-week low of $20.92 on Wednesday but recovered thereafter and closed at $22.49 Though the stock has seen ups and downs in the past year, the latest price decline is ...

NEW YORK: Long-threatened tariffs from US President Donald Trump have plunged the country into trade wars abroad - all while on-again, off-again new levies continue to escalate uncertainty ...

Stocks like Pfizer, Amgen, Johnson & Johnson, and Eli Lilly & Co. were among others which opened lower after the US stock market opened on Wednesday. Pfizer Inc. shares are currently trading 2.56 ...

Pharmaceutical giant Pfizer sold its longtime San Diego campus to a life science-focused commercial real estate company in one of the largest deals of the past year. Pfizer sold the five ...

Pfizer Inc.’s longtime chief scientist is joining Blackstone Inc. to advise the private equity giant on its investments into advanced new medicines. Mikael Dolsten, who retired from Pfizer late ...